GABA能抑制改变与抑郁及其他脑疾病认知功能障碍
本文综述抑郁、其他精神疾病及衰老中认知功能障碍与GABA系统改变的关系,重点涉及表达生长抑素的GABA能中间神经元(SST+)及α5-GABA-A受体。实验性降低SST+神经元功能可损害认知,而增强SST+细胞突触后α5-GABA-A受体活性在应激和衰老模型中具有促认知效果,提示该通路是改善情绪和认知症状的新靶点。
要点
- 抑郁发作期认知障碍常持续至缓解期,预测复发且现有抗抑郁药未治疗。
- SST+中间神经元调控锥体神经元兴奋性输入,其功能降低导致认知障碍。
- 增强SST+细胞突触后α5-GABA-A受体活性在应激和衰老模型中促认知。
核心结论
- SST+神经元/α5-GABA-A受体通路信号减弱可能导致认知功能障碍。
- 该通路是改善抑郁、其他精神疾病及衰老中情绪和认知症状的新治疗靶点。
研究设计与样本
- 综述整合了人类受试者的细胞、分子和生化研究以及实验模型证据。
主要发现
- 抑郁发作期存在注意、学习、记忆、计划和问题解决等认知功能障碍,常持续至缓解期并预测复发。
- 认知症状也见于其他精神疾病、衰老及阿尔茨海默病等晚发性疾病。
- 人类研究报道GABA系统改变,特别是SST+ GABA能中间神经元,跨脑疾病和衰老出现变化。
- 实验性降低SST+神经元功能影响兴奋性信噪比、减少同步化细胞和神经活动并导致认知障碍。
- 增强SST+细胞突触后α5-GABA-A受体活性在应激和衰老模型中具有促认知效果。
临床怎么用
- 关注抑郁患者认知症状的持续存在及其对复发的影响。
- SST+神经元/α5-GABA-A受体通路可作为认知症状的潜在治疗靶点。
局限性
- 原文未报告综述的检索范围、纳入标准或证据质量评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cognitive dysfunctions, including impaired attention, learning, memory, planning and problem solving, occur in depressive episodes, often persist during remission, predict relapse, worsen with recurrent episodes, and are not treated by current antidepressants or other medications. Cognitive symptoms are also present in other psychiatric disorders, are a hallmark of aging, and define several late-life disorders, including Alzheimer's disease. This pervasive occurrence suggests either a non-specific outcome of a diseased brain, or a shared underlying pathology contributing to this symptom dimension. Recent findings suggest a role for altered GABAergic inhibition in cognitive symptoms. Cellular, molecular and biochemical studies in human subjects report changes affecting the gamma-amino butyric acid (GABA) system, specifically somatostatin-expressing (SST+) GABAergic interneurons, across brain disorders and during aging. SST+ neurons gate excitatory input onto pyramidal neurons within cortical microcircuits. Experimentally reducing the function of these neurons affects excitatory signal-to-noise ratio, reduces synchronized cellular and neural activity, and leads to cognitive dysfunctions. Conversely, augmenting SST+ cell post-synaptic α5-GABA-A receptor activity has pro-cognitive efficacy in stress and aging models. Together, this suggests that reduced signaling of the SST+ neuron/α5-GABA-A receptor pathway contributes to cognitive dysfunctions, and that it represents a novel therapeutic target for remediating mood and cognitive symptoms in depression, other psychiatric disorders and during aging.
引用
- Prévot T, Sibille E. Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders. Mol Psychiatry. 2020. PMID: 32346158. doi:10.1038/s41380-020-0727-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。